{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:16:51Z","timestamp":1778894211014,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMS- 2052592"],"award-info":[{"award-number":["DMS- 2052592"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Modelling"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.idm.2025.06.003","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:22:28Z","timestamp":1751023348000},"page":"1229-1237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Wonder drugs and where to use them: a forecast of ivermectin's impact on malaria in Africa"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2484-4147","authenticated-orcid":false,"given":"Scott","family":"Greenhalgh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmani","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-0996","authenticated-orcid":false,"given":"Ashley","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idm.2025.06.003_bib1","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.1999.61.109","article-title":"Short report: Entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa","author":"Beier","year":"1999","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1016\/j.idm.2025.06.003_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.idm.2017.04.001","article-title":"Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum","volume":"2","author":"Brock","year":"2017","journal-title":"Infectious Disease Modelling"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-016-1650-6","article-title":"Incidence and admission rates for severe malaria and their impact on mortality in Africa","volume":"16","author":"Camponovo","year":"2017","journal-title":"Malaria Journal"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/653208","article-title":"Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: The potential of oral insecticides in malaria control","volume":"202","author":"Chaccour","year":"2010","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.idm.2025.06.003_bib5","article-title":"Ivermectin to reduce malaria transmission\u2014safety and efficacy results from the BOHEMIA cluster randomized trial in Mozambique","author":"Chaccour","year":"2025","journal-title":"SSRN"},{"issue":"2","key":"10.1016\/j.idm.2025.06.003_bib6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4269\/ajtmh.17-0042","article-title":"Serious neurological adverse events after ivermectin\u2014do they occur beyond the indication of onchocerciasis?","volume":"98","author":"Chandler","year":"2018","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1016\/j.idm.2025.06.003_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/inthealth\/ihw027","article-title":"Antimalarial mass drug administration: Ethical considerations","volume":"8","author":"Cheah","year":"2016","journal-title":"International Health"},{"issue":"5","key":"10.1016\/j.idm.2025.06.003_bib8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s11538-008-9299-0","article-title":"Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model","volume":"70","author":"Chitnis","year":"2008","journal-title":"Bulletin of Mathematical Biology"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40249-016-0151-8","article-title":"Malaria: Global progress 2000 \u2013 2015 and future challenges","volume":"5","author":"Cibulskis","year":"2016","journal-title":"Infectious Diseases of Poverty"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002032","article-title":"African programme for onchocerciasis control 1995\u20132015: Model-estimated health impact and cost","volume":"7","author":"Coffeng","year":"2013","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"10","key":"10.1016\/j.idm.2025.06.003_bib11","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","article-title":"Antimalarial drug resistance in Africa: The calm before the storm?","volume":"19","author":"Conrad","year":"2019","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.idm.2025.06.003_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104814","article-title":"Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Male and female Gabonese adults \u2013 A pilot randomized, double-blind, placebo-controlled single-centre phase Ib\/IIa clinical trial","volume":"97","author":"Ekoka Mbassi","year":"2023","journal-title":"EBioMedicine"},{"issue":"15","key":"10.1016\/j.idm.2025.06.003_bib13","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1073\/pnas.1011250108","article-title":"Adaptive human behavior in epidemiological models","volume":"108","author":"Fenichel","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"12","key":"10.1016\/j.idm.2025.06.003_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.0030255","article-title":"Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model","volume":"3","author":"Filipe","year":"2005","journal-title":"PLoS Computational Biology"},{"key":"10.1016\/j.idm.2025.06.003_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)32321-3","article-title":"Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): A cluster-randomised trial","author":"Foy","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.idm.2025.06.003_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)32321-3","article-title":"Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): A cluster-randomised trial","author":"Foy","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.idm.2025.06.003_bib17","doi-asserted-by":"crossref","DOI":"10.2196\/41197","article-title":"Repeat ivermectin mass drug administrations for malaria control II: Protocol for a double-blind, cluster-randomized, placebo-controlled trial for the integrated control of malaria","volume":"12","author":"Foy","year":"2023","journal-title":"JMIR Research Protocols"},{"key":"10.1016\/j.idm.2025.06.003_bib18","series-title":"Trends in parasitology","article-title":"Ivermectin 20 years on: Maturation of a wonder drug","author":"Geary","year":"2005"},{"key":"10.1016\/j.idm.2025.06.003_bib19","article-title":"mathguypi314\/GSISmodel: gSIS model (version v1.0.0)","author":"Greenhalgh","year":"2022","journal-title":"Zenodo"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12889-019-8141-y","article-title":"Advocating an attack against severe malaria: A cost-effectiveness analysis","volume":"20","author":"Greenhalgh","year":"2020","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.idm.2025.06.003_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/QAI.0000000000001783","article-title":"Brief report: Antimalarial benefit of HIV antiretroviral therapy in areas of low to moderate malaria transmission intensity","volume":"79","author":"Greenhalgh","year":"2018","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"8","key":"10.1016\/j.idm.2025.06.003_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000324","article-title":"Reducing Plasmodium falciparum malaria transmission in Africa: A model-based evaluation of intervention strategies","volume":"7","author":"Griffin","year":"2010","journal-title":"PLoS Medicine"},{"issue":"10","key":"10.1016\/j.idm.2025.06.003_bib23","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/heapol\/czw062","article-title":"Public health interventions to protect against falsified medicines: A systematic review of international, national and local policies","volume":"31","author":"Hamilton","year":"2016","journal-title":"Health Policy and Planning"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s43856-023-00373-y","article-title":"Modeling of malaria vaccine effectiveness on disease burden and drug resistance in 42 African countries","volume":"3","author":"Hamilton","year":"2023","journal-title":"Communication and Medicine"},{"issue":"3","key":"10.1016\/j.idm.2025.06.003_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/inthealth\/ihy079","article-title":"The promise, problems and pitfalls of mass drug administration for malaria elimination: A qualitative study with scientists and policymakers","volume":"11","author":"Kaehler","year":"2019","journal-title":"International Health"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3961\/jpmph.21.597","article-title":"DALY estimation approaches: Understanding and using the incidence-based approach and the prevalence-based approach","volume":"55","author":"Kim","year":"2022","journal-title":"Journal of Preventive Medicine and Public Health = Yebang Uihakhoe Chi"},{"issue":"9","key":"10.1016\/j.idm.2025.06.003_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004056","article-title":"Financial and economic costs of the elimination and eradication of onchocerciasis (river blindness) in Africa","volume":"9","author":"Kim","year":"2015","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"9","key":"10.1016\/j.idm.2025.06.003_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000464","article-title":"Community access to rectal artesunate for malaria (CARAMAL): A large-scale observational implementation study in the democratic Republic of the Congo, Nigeria and Uganda","volume":"2","author":"Lengeler","year":"2022","journal-title":"PLOS Global Public Health"},{"issue":"3","key":"10.1016\/j.idm.2025.06.003_bib29","first-page":"429","article-title":"Quantifying the burden of disease: The technical basis for disability-adjusted life years","volume":"72","author":"Murray","year":"1994","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","article-title":"Review of mass drug administration for malaria and its operational challenges","volume":"93","author":"Newby","year":"2015","journal-title":"The American Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib31","first-page":"11","article-title":"The efficacy of topical and oral ivermectin in the treatment of human scabies","volume":"61","author":"Panahi","year":"2015","journal-title":"Annals of Parasitology"},{"issue":"6","key":"10.1016\/j.idm.2025.06.003_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/00034983.1986.11812076","article-title":"Response of laboratory-adapted human hookworm and other nematodes to ivermectin","volume":"80","author":"Rajasekariah","year":"1986","journal-title":"Annals of Tropical Medicine and Parasitology"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.2011.11-0160","article-title":"Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages","volume":"85","author":"Sarr","year":"2011","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1016\/j.idm.2025.06.003_bib34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12889-017-4414-5","article-title":"A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in Sub-Saharan Africa","volume":"17","author":"Silumbwe","year":"2017","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.idm.2025.06.003_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(19)30633-4","article-title":"Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: A modelling study","volume":"20","author":"Slater","year":"2020","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.idm.2025.06.003_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiu351","article-title":"The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: A modelling study","author":"Slater","year":"2014","journal-title":"Journal of Infectious Diseases"},{"issue":"1\u20133","key":"10.1016\/j.idm.2025.06.003_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0378-4754(00)00270-6","article-title":"Global sensitivity indices for nonlinear mathematical models and their monte carlo estimates","volume":"55","author":"Sobol","year":"2001","journal-title":"Mathematics and Computers in Simulation"},{"key":"10.1016\/j.idm.2025.06.003_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115838","article-title":"Antiparasitic activity of ivermectin: Four decades of research into a \u201cwonder drug.\u201d","volume":"261","author":"Sulik","year":"2023","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"2s","key":"10.1016\/j.idm.2025.06.003_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.19-0620","article-title":"A roadmap for the development of ivermectin as a complementary malaria vector control tool","volume":"102","author":"The Ivermectin","year":"2020","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.idm.2025.06.003_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00016-8","article-title":"The 2023 WHO world malaria report","author":"Venkatesan","year":"2024","journal-title":"The Lancet Microbe"},{"issue":"4","key":"10.1016\/j.idm.2025.06.003_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3156.2004.01210.x","article-title":"Economic evaluation of mectizan distribution","volume":"9","author":"Waters","year":"2004","journal-title":"Tropical Medicine and International Health"},{"key":"10.1016\/j.idm.2025.06.003_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1475-2875-10-337","article-title":"Costs and cost-effectiveness of malaria control interventions\u2014A systematic review","volume":"10","author":"White","year":"2011","journal-title":"Malaria Journal"},{"issue":"2","key":"10.1016\/j.idm.2025.06.003_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-777X.81692","article-title":"River blindness: An old disease on the brink of elimination and control","volume":"3","author":"Winthrop","year":"2011","journal-title":"Journal of Global Infectious Diseases"},{"key":"10.1016\/j.idm.2025.06.003_bib44","series-title":"WHO status reports on artemisinin resistance and ACT efficacy","year":"2019"},{"issue":"32","key":"10.1016\/j.idm.2025.06.003_bib47","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2021.05.075","article-title":"Promoting, seeking, and reaching vaccination services: A systematic review of costs to immunization programs, beneficiaries, and caregivers","volume":"39","author":"Yemeke","year":"2021","journal-title":"Vaccine"}],"container-title":["Infectious Disease Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468042725000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468042725000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:54:54Z","timestamp":1778892894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468042725000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2468042725000533"],"URL":"https:\/\/doi.org\/10.1016\/j.idm.2025.06.003","relation":{},"ISSN":["2468-0427"],"issn-type":[{"value":"2468-0427","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wonder drugs and where to use them: a forecast of ivermectin's impact on malaria in Africa","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idm.2025.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd\u00e9","name":"copyright","label":"Copyright"}]}}